About NanoSyrinx
NanoSyrinx is a company based in Coventry (United Kingdom) founded in 2018 by Nick R Waterfield and Joe Healey.. NanoSyrinx has raised $21.63 million across 5 funding rounds from investors including Lilly, BioCity and BGF. The company has 17 employees as of September 30, 2023. NanoSyrinx offers products and services including Nanosyringe Platform. NanoSyrinx operates in a competitive market with competitors including Sirnaomics, Liquidia, Acorda, Genedit and Ensysce, among others.
- Headquarter Coventry, United Kingdom
- Employees 17 as on 30 Sep, 2023
- Founders Nick R Waterfield, Joe Healey
-
Sectors
TechnologyHealthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nanosyrinx Ltd
- Date of Incorporation 29 Sep, 2018
- Jurisdiction COVENTRY, WEST MIDLANDS, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$21.63 M (USD)
in 5 rounds
-
Latest Funding Round
$13.1 M (USD), Series A
Sep 10, 2024
-
Investors
Lilly
& 9 more
-
Employee Count
17
as on Sep 30, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NanoSyrinx
NanoSyrinx offers a comprehensive portfolio of products and services, including Nanosyringe Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables targeted delivery of biologic molecules into cells for therapeutic use.
Unlock access to complete
Unlock access to complete
Funding Insights of NanoSyrinx
NanoSyrinx has successfully raised a total of $21.63M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $13.1 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $13.1M
- First Round First Round
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Series A - NanoSyrinx | Valuation | BGF , Octopus Ventures | |
| Jul, 2021 | Amount | Seed - NanoSyrinx | Valuation | Octopus Ventures | |
| Sep, 2020 | Amount | Seed - NanoSyrinx | Valuation | M Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NanoSyrinx
NanoSyrinx has secured backing from 10 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Lilly, BioCity and BGF. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early & Growth stage tech & offline focused VC firm funding companies in the UK & Ireland
|
Founded Year | Domain | Location | |
|
Venture capital investment and support for founders in technology and health sectors.
|
Founded Year | Domain | Location | |
|
Deep tech venture capital firm investing in European and global startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NanoSyrinx
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NanoSyrinx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nanosyrinx Comparisons
Competitors of NanoSyrinx
NanoSyrinx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sirnaomics, Liquidia, Acorda, Genedit and Ensysce, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
RNA-based therapeutics for cancer and fibrosis are developed.
|
|
| domain | founded_year | HQ Location |
Engineered particles & films for life and material sciences applications
|
|
| domain | founded_year | HQ Location |
Engaged in the development and commercialization of therapies that improve neurological function.
|
|
| domain | founded_year | HQ Location |
Genetic medicines are delivered using polymer nanoparticle platforms.
|
|
| domain | founded_year | HQ Location |
Drug delivery solutions via single-walled carbon nanotubes are offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nanosyrinx
Frequently Asked Questions about NanoSyrinx
When was NanoSyrinx founded?
NanoSyrinx was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Where is NanoSyrinx located?
NanoSyrinx is headquartered in Coventry, United Kingdom.
Who is the current CEO of NanoSyrinx?
Joe Healey is the current CEO of NanoSyrinx. They have also founded this company.
Is NanoSyrinx a funded company?
NanoSyrinx is a funded company, having raised a total of $21.63M across 5 funding rounds to date.
How many employees does NanoSyrinx have?
As of Sep 30, 2023, the latest employee count at NanoSyrinx is 17.
What does NanoSyrinx do?
NanoSyrinx was established in 2018 in Coventry, United Kingdom, within the biotechnology sector. A genetically encoded drug delivery device is created using nanosyringes to target cell interiors. The system is designed for production and loading through upstream genetics alone, eliminating further preparation steps. Operations center on advancing intracellular drug administration technologies for potential therapeutic applications.
Who are the top competitors of NanoSyrinx?
NanoSyrinx's top competitors include Sirnaomics, Arcturus Therapeutics and Acorda.
What products or services does NanoSyrinx offer?
NanoSyrinx offers Nanosyringe Platform.
Who are NanoSyrinx's investors?
NanoSyrinx has 10 investors. Key investors include Lilly, BioCity, BGF, Octopus Ventures, and IQ Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.